Fenix — Find Research. Find Hope.
Find trials

All Huntington's Disease Trials

Browse all active Huntington's disease trials in one place. Filter the list yourself, or let Fenix recommend studies that may be relevant to you or someone you care about.

Takes about a minute. No account needed.

Research Updates

Stay informed about new research. New trials are added over time. Get notified when fresh Huntington's disease research opportunities become available so you don't miss future options.

Explore studies mentioning…
Showing 4 of 103 active studiesUpdated 22 Aug 2026

A Phase I Randomised, Double Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics

Related trial records · Skyhawk Therapeutics, Inc.

Phase 1 study testing an investigational treatment in healthy participants.

RecruitingPhase 1DrugANZCTRTreatment trial
Recruiting in: AustraliaExact site not listed by the study registry.
Preparing a short plain-English summary.
View on ANZCTR

An Extension of SKY-0515 in Participants With Huntington's Disease

Skyhawk Therapeutics, Inc.

Phase 2/3 study testing SKY-0515 to see whether it can lower harmful huntingtin protein levels.

Active, not recruitingPhase 2 / Phase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Adelaide, Auckland, Caulfield South +7 more (Australia, New Zealand)
Preparing a short plain-English summary.
View on ClinicalTrials.gov

Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

Falcon-HD · Skyhawk Therapeutics, Inc.

Phase 2/3 study testing SKY-0515 to see whether it can lower harmful huntingtin protein levels.

Active, not recruitingPhase 2 / Phase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Adelaide, Auckland, Caulfield South +8 more (Australia, New Zealand)
Preparing a short plain-English summary.
View on ClinicalTrials.gov

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

FALCON-HD · Skyhawk Therapeutics, Inc.

Phase 2/3 study testing SKY-0515 to see whether it can lower harmful huntingtin protein levels.

RecruitingPhase 2 / Phase 3DrugClinicalTrials.govTreatment trial
  • EU sites have not started recruiting yet
Recruiting in: Barranquilla, Belo Horizonte, Buenos Aires +12 more (Argentina, Brazil, Canada +6 more)
Preparing a short plain-English summary.
View on ClinicalTrials.gov